Biolytica
Zug
About Biolytica
The Biolytica NEXUS platform is the first fully integrated tool to enable prevention-focused clinicians and longevity professionals to create hyper-personalized, data-driven, health optimization journeys for their clients. NEXUS is the only tool in the market that allows for the integration, visualization, correlation and analysis of data from genomics, epigenetics, digital and physical biomarkers, nutrition / lifestyle information, questionnaires and various other datapoints, allowing clinicians to not only be more precise in their health interventions, but to also track and monitor progress, create personalized action plans and stay in touch with clients, allowing them to lower churn rate of their offerings and open new revenue potentials through additional service models.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.9M
- Funding stage: Seed
- Last round: Seed (May 2023)
- Website: biolytica.com
- Phone: +41 (0)41 515 5454
Industries & Categories
Electronic Health Record (EHR), Health Care, Health Diagnostics, Medical, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/biolytica-84513 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.